Christina Lake CannabisCLCFF -10.51% 3-Year ROIIC % is 22.53 as of Nov. 2023, which is 230% above its 10-year median of 6.83. The stock has 5 warning signs investors should review. Among 943 Drug Manufacturers companies, Christina Lake Cannabis ranks better than 72.53% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Christina Lake Cannabis's 3-Year ROIIC % for the quarter that ended in Nov. 2023 was 22.53%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Christina Lake Cannabis's 3-Year ROIIC % or its related term are showing as below:
CLCFF's 3-Year ROIIC % is ranked better than 72.53% of 943
companies
in the Drug Manufacturers industry
Industry Median: 3.74
vs CLCFF: 22.53
Christina Lake Cannabis (OTCPK:CLCFF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Christina Lake Cannabis 3-Year ROIIC % Related Terms
Christina Lake Cannabis 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's 3-Year ROIIC % falls into.
Christina Lake Cannabis 3-Year ROIIC % Calculation
Christina Lake Cannabis's 3-Year ROIIC % for the quarter that ended in Nov. 2023 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.808 (Nov. 2023) - -0.306 (Nov. 2020) )
/
( 8.861 (Nov. 2023) - 11.695 (Nov. 2020) )
=
-0.502
/
-2.834
=
17.71%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Christina Lake Cannabis (CLCFF) has a 3-Year ROIIC % of 22.53 as of Nov. 2023. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Christina Lake Cannabis and its competitors. This is 230% above median its historical median of 6.83. According to the industry distribution chart, Christina Lake Cannabis ranks #259 out of 943 companies in the Drug Manufacturers industry, placing it in the top 27.5%.
Is Christina Lake Cannabis' 3-Year ROIIC % too high?
Christina Lake Cannabis' current 3-Year ROIIC % of 22.53 is 230% above median its 10-year median of 6.83. The Drug Manufacturers industry median 3-Year ROIIC % is 3.74. Christina Lake Cannabis' value of 22.53 is 502.4% above this industry median. Based on the distribution chart, Christina Lake Cannabis ranks #259 out of 943 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Christina Lake Cannabis' 3-Year ROIIC % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #259 out of 943 companies for 3-Year ROIIC %. This puts Christina Lake Cannabis in the upper half of its industry. The industry median 3-Year ROIIC % is 3.74. Christina Lake Cannabis' value of 22.53 is 502.4% above this benchmark. While the company's 10-year median is 6.83 vs. the industry median of 3.74, Christina Lake Cannabis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.74, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Christina Lake Cannabis's current 3-Year ROIIC % of 22.53 is 502.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current 3-Year ROIIC % is 22.53, which is 230% above median its own 10-year median of 6.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.04, compared to a current price of $0.02 — trading 52.3% below its estimated fair value. The current 3-Year ROIIC % is 22.53, which is 230% above median its 10-year median of 6.83 and 502.4% above the Drug Manufacturers industry median of 3.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current 3-Year ROIIC % is 22.53 as of Nov. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCFF has been successfully added to your 